Don't get left behind! The modernized is coming. Check it out now.
Say goodbye to!
The new site is coming soon - go to the modernized
Working… Menu

Transfusion in Sickle Cell Disease: Risk Factors for Alloimmunization

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03405402
Recruitment Status : Completed
First Posted : January 23, 2018
Last Update Posted : January 28, 2021
Information provided by (Responsible Party):
Hanane EL KENZ, Brugmann University Hospital

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 3, 2020
Actual Study Completion Date : August 3, 2020